Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Google is still growing 21 percent — and its cloud segment is growing even faster

Despite a $2.7 billion fine, Google’s parent company beat expectations for revenue and profits.

Google CEO Sundar Pichai Opens I/O Developer Conference
Google CEO Sundar Pichai Opens I/O Developer Conference
Google CEO Sundar Pichai
Justin Sullivan / Getty

Google’s parent company Alphabet just reported its second-quarter results, posting both higher revenue and profits than estimated.

Of note:

  • Overall, Alphabet revenue grew 21 percent year over year to $26 billion. Google revenue, specifically, also grew 21 percent to $25.8 billion.
  • Google’s “other” business — everything that’s not advertising, including its cloud business and Google Play app store — grew 42 percent year over year to $3.1 billion.
  • “Other” now represents 12 percent of Google’s business, up from about 10 percent the same quarter a year ago.
  • The Alphabet “Other Bets” — experimental businesses like Waymo’s self-driving car technology and Verily’s health care products — posted both higher revenue and smaller losses. Revenue grew 34 percent year over year to $248 million, while its operating loss declined 10 percent to $772 million.
  • The “Other Bets” now represent about 1 percent of Alphabet’s total revenue.

Overall, Alphabet earned $5.01 per share on $26 billion in sales during the quarter, versus expectations of $4.83 earnings per share and $25.6 billion in revenue.

Profit estimates were lower than normal on account of a one-time fine from European regulators over anti-competitive behavior for its product listing ads. They charged the search giant with favoring certain results that were part of its special product advertising program. The company recorded the fine — $2.7 billion — in the quarter as an additional operating loss.

Alphabet is likely to appeal the ruling, but if it has to change how it sells and displays those kinds of ads in Europe, it could dent its longer-term revenue. Sales from the EMEA region account for about 34 percent of the company’s overall revenue, and these so-called product listings ads in the region could drop by as much as 25 percent according to a Goldman Sachs estimate.

Alphabet stock was down about 3 percent in after-hours trading ahead of its earnings call.


This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh